Zoetis Inc (ZTS) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Over the past 4 years, Zoetis Inc has achieved a revenue compound annual growth rate (CAGR) of 8.5%, while earnings have grown at 11.1% CAGR.
Historical revenue and profitability trends for Zoetis Inc
The chart above illustrates Zoetis Inc's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.
Annual percentage change in revenue and earnings
Growth rates provide insight into the momentum of Zoetis Inc's business.
How efficiently Zoetis Inc converts revenue into profit
Profit margins reveal how much of each dollar of revenue Zoetis Inc retains at different stages:
Analyst estimates and forward-looking indicators
Wall Street analysts project Zoetis Inc to continue growing earnings in the coming year. The consensus analyst rating is 4.2632 based on 19 analysts.
Based on our comprehensive analysis, Zoetis Inc (ZTS) demonstrates declining growth characteristics.
This growth analysis provides a comprehensive view of Zoetis Inc's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.
See how Zoetis Inc stacks up against similar companies
Explore growth analysis for top stocks
Related: ZTS Valuation, ZTS Dividend, ZTS Financial Health
Compare: ZTS vs AAPL, ZTS vs MSFT, ZTS vs GOOGL